USFDA inspects Divis Laboratories’ Unit-I at Hyderabad

21 Jun 2014 Evaluate

Divis Laboratories’ Unit-I at Lingojigudem village, Choutuppal Mandal near Hyderabad has been successfully inspected by the USFDA from June 16-20, 2014, without any observations. The purpose of this inspection was for general Current Good Manufacturing Practices for the facility.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Divis Lab Share Price

4586.75 -6.25 (-0.14%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.